Literature DB >> 22493442

Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression.

Heesung Chung1, Jung-hyun Lee, Dayun Jeong, Inn-Oc Han, Eok-Soo Oh.   

Abstract

The melanocortin 1 receptor (MC1R), a key regulator of melanogenesis, is known to control inflammation, acting in concert with the MC1R ligand α-melanocyte-stimulating hormone. Although cell migration is a key event in inflammation, few studies have addressed the function of MC1R in this context. Using highly motile melanoma cells, we found that the expression level of MC1R was associated with the extent of migration of mouse melanoma cells, suggesting that MC1R plays a functional role in controlling this migration. Overexpression of MC1R enhanced melanoma cell migration, whereas the opposite was true when MC1R levels were knocked down using small inhibitory RNAs. Interestingly, MC1R expression enhanced the synthesis of syndecan-2, a cell surface heparan sulfate proteoglycan known to be involved in melanoma cell migration. Knockdown of syndecan-2 expression decreased MC1R-mediated cell migration. Further, MC1R inhibited the activation of p38 MAPK, subsequently enhancing expression of sydnecan-2, in parallel with an increase in the extent of cell migration. Consistently, activation of p38 by H(2)O(2) inhibited syndecan-2 expression and cell migration, whereas inhibition of p38 activation enhanced syndecan-2 expression and cell migration. Finally, we found that α-melanocyte-stimulating hormone inhibited MC1R-mediated cell migration via activation of p38 and inhibition of syndecan-2 expression. Together, the data strongly suggest that MC1R regulates melanoma cell migration via inhibition of syndecan-2 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493442      PMCID: PMC3365964          DOI: 10.1074/jbc.M111.334730

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Syndecan-2 is essential for angiogenic sprouting during zebrafish development.

Authors:  Eleanor Chen; Spencer Hermanson; Stephen C Ekker
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

2.  B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone.

Authors:  F F Solca; J Chluba-de Tapia; K Iwata; A N Eberle
Journal:  FEBS Lett       Date:  1993-05-10       Impact factor: 4.124

3.  Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.

Authors:  G Poste; J Doll; A E Brown; J Tzeng; I Zeidman
Journal:  Cancer Res       Date:  1982-07       Impact factor: 12.701

4.  Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone.

Authors:  Ningwen Zhu; Paula C Eves; Effie Katerinaki; Marika Szabo; Renato Morandini; Ghanem Ghanem; Paul Lorigan; Sheila MacNeil; John W Haycock
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

5.  Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans.

Authors:  P Valverde; E Healy; I Jackson; J L Rees; A J Thody
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

6.  Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.

Authors:  J Chluba-de Tapia; C Bagutti; R Cotti; A N Eberle
Journal:  J Cell Sci       Date:  1996-08       Impact factor: 5.285

7.  Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone.

Authors:  N Zhu; R Lalla; P Eves; T L H Brown; A King; E H Kemp; J W Haycock; S MacNeil
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

8.  Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells.

Authors:  P Eves; J Haycock; C Layton; M Wagner; H Kemp; M Szabo; R Morandini; G Ghanem; J C García-Borrón; C Jiménez-Cervantes; S Mac Neil
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

9.  Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors.

Authors:  M De Luca; W Siegrist; S Bondanza; M Mathor; R Cancedda; A N Eberle
Journal:  J Cell Sci       Date:  1993-08       Impact factor: 5.285

10.  Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker.

Authors:  F Salazar-Onfray; M López; A Lundqvist; A Aguirre; A Escobar; A Serrano; C Korenblit; M Petersson; V Chhajlani; O Larsson; R Kiessling
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

View more
  15 in total

1.  Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue.

Authors:  Mikhail O Durymanov; Tatiana A Slastnikova; Alexey I Kuzmich; Yuri V Khramtsov; Alexey V Ulasov; Andrey A Rosenkranz; Sergey Y Egorov; Eugene D Sverdlov; Alexander S Sobolev
Journal:  Biomaterials       Date:  2013-09-27       Impact factor: 12.479

2.  Immunosuppressive mechanisms of regulatory dendritic cells in cancer.

Authors:  Galina V Shurin; Yang Ma; Michael R Shurin
Journal:  Cancer Microenviron       Date:  2013-06-09

3.  miR-218 affects the ECM composition and cell biomechanical properties of glioblastoma cells.

Authors:  Małgorzata Grabowska; Konrad Kuczyński; Monika Piwecka; Alicja Rabiasz; Joanna Zemła; Paweł Głodowicz; Dariusz Wawrzyniak; Małgorzata Lekka; Katarzyna Rolle
Journal:  J Cell Mol Med       Date:  2022-06-15       Impact factor: 5.295

Review 4.  Malignant melanoma and melanocortin 1 receptor.

Authors:  A A Rosenkranz; T A Slastnikova; M O Durymanov; A S Sobolev
Journal:  Biochemistry (Mosc)       Date:  2013-11       Impact factor: 2.487

5.  Spherical Nucleic Acids for Topical Treatment of Hyperpigmentation.

Authors:  Yang Fang; Xueguang Lu; Dali Wang; Jiansong Cai; Yuyan Wang; Peiru Chen; Mengqi Ren; Hao Lu; Jennifer Union; Lei Zhang; Yehui Sun; Fei Jia; Xi Kang; Xuyu Tan; Ke Zhang
Journal:  J Am Chem Soc       Date:  2021-01-12       Impact factor: 15.419

6.  A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.

Authors:  Carlos R Figueiredo; Alisson L Matsuo; Ricardo A Azevedo; Mariana H Massaoka; Natalia Girola; Luciano Polonelli; Luiz R Travassos
Journal:  Sci Rep       Date:  2015-09-22       Impact factor: 4.379

7.  Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.

Authors:  Sojoong Choi; Youngsil Choi; Eunsung Jun; In-San Kim; Seong-Eun Kim; Sung-Ae Jung; Eok-Soo Oh
Journal:  Oncotarget       Date:  2015-02-28

8.  Alkbh4 and Atrn Act Maternally to Regulate Zebrafish Epiboly.

Authors:  Qingrui Sun; Xingfeng Liu; Bo Gong; Di Wu; Anming Meng; Shunji Jia
Journal:  Int J Biol Sci       Date:  2017-09-02       Impact factor: 6.580

9.  PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.

Authors:  Guanzhen Yu; Wenlong Yu; Guangzhi Jin; Dongyun Xu; Ying Chen; Tian Xia; Allan Yu; Wenzheng Fang; Xiaoli Zhang; Zhaosheng Li; Keping Xie
Journal:  Mol Cancer       Date:  2015-11-14       Impact factor: 27.401

10.  Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants.

Authors:  Sander Bekeschus; Katrin Rödder; Bob Fregin; Oliver Otto; Maxi Lippert; Klaus-Dieter Weltmann; Kristian Wende; Anke Schmidt; Rajesh Kumar Gandhirajan
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.